MX2022013857A - Composiciones que comprenden tropoelastina reticulada con ácido hialurónico y métodos de uso de estas. - Google Patents
Composiciones que comprenden tropoelastina reticulada con ácido hialurónico y métodos de uso de estas.Info
- Publication number
- MX2022013857A MX2022013857A MX2022013857A MX2022013857A MX2022013857A MX 2022013857 A MX2022013857 A MX 2022013857A MX 2022013857 A MX2022013857 A MX 2022013857A MX 2022013857 A MX2022013857 A MX 2022013857A MX 2022013857 A MX2022013857 A MX 2022013857A
- Authority
- MX
- Mexico
- Prior art keywords
- tropoelastin
- crosslinked
- hyaluronic acid
- compositions
- methods
- Prior art date
Links
- 102100033167 Elastin Human genes 0.000 title abstract 5
- 108010014258 Elastin Proteins 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title abstract 4
- 229920002674 hyaluronan Polymers 0.000 title abstract 4
- 229960003160 hyaluronic acid Drugs 0.000 title abstract 4
- 210000004872 soft tissue Anatomy 0.000 abstract 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
Abstract
Las afecciones de los tejidos blandos se pueden tratar mediante la administración de una composición que comprende tropoelastina que incluye, por ejemplo, una composición que comprende tropoelastina reticulada con ácido hialurónico para aumentar el contenido de humedad en el tejido blando. Además, las afecciones de los tejidos blandos se pueden tratar mediante la administración de una composición de tropoelastina reticulada con ácido hialurónico en una proporción de 2:1 o mayor que aumenta el contenido de humedad en el tejido blando en relación con una composición idéntica donde la proporción de tropoelastina reticulada con ácido hialurónico es menor que 2:1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063025078P | 2020-05-14 | 2020-05-14 | |
| PCT/IB2021/054177 WO2021229544A1 (en) | 2020-05-14 | 2021-05-14 | Compositions comprising tropoelastin crosslinked to hyaluronic acid and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022013857A true MX2022013857A (es) | 2023-02-09 |
Family
ID=76059945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022013857A MX2022013857A (es) | 2020-05-14 | 2021-05-14 | Composiciones que comprenden tropoelastina reticulada con ácido hialurónico y métodos de uso de estas. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230255875A1 (es) |
| EP (1) | EP4149578A1 (es) |
| JP (1) | JP2023525155A (es) |
| KR (1) | KR20230012532A (es) |
| CN (1) | CN115768496A (es) |
| AU (1) | AU2021272472A1 (es) |
| BR (1) | BR112022023209A2 (es) |
| CA (1) | CA3177686A1 (es) |
| MX (1) | MX2022013857A (es) |
| WO (1) | WO2021229544A1 (es) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG93791A1 (en) | 1992-12-22 | 2003-01-21 | Univ Sydney | Synthetic polynucleotides |
| AUPO811797A0 (en) | 1997-07-18 | 1997-08-14 | University Of Sydney, The | Tropoelastin derivatives |
| US6000849A (en) | 1998-06-26 | 1999-12-14 | 3M Innovative Properties Company | Gift package |
| AUPP472398A0 (en) | 1998-07-17 | 1998-08-13 | University Of Sydney, The | Protease susceptibility II |
| AU2011334599B2 (en) | 2010-11-23 | 2016-12-01 | Allergan Pharmaceuticals International Limited | Preparation and/or formulation of proteins cross-linked with polysaccharides |
| CN103841990A (zh) * | 2011-09-30 | 2014-06-04 | 悉尼大学 | 弹性纤维的体内合成 |
-
2021
- 2021-05-14 JP JP2022569121A patent/JP2023525155A/ja active Pending
- 2021-05-14 BR BR112022023209A patent/BR112022023209A2/pt unknown
- 2021-05-14 EP EP21727253.3A patent/EP4149578A1/en active Pending
- 2021-05-14 CA CA3177686A patent/CA3177686A1/en active Pending
- 2021-05-14 WO PCT/IB2021/054177 patent/WO2021229544A1/en unknown
- 2021-05-14 US US17/998,763 patent/US20230255875A1/en active Pending
- 2021-05-14 KR KR1020227043554A patent/KR20230012532A/ko unknown
- 2021-05-14 MX MX2022013857A patent/MX2022013857A/es unknown
- 2021-05-14 CN CN202180037642.7A patent/CN115768496A/zh active Pending
- 2021-05-14 AU AU2021272472A patent/AU2021272472A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4149578A1 (en) | 2023-03-22 |
| CN115768496A (zh) | 2023-03-07 |
| BR112022023209A2 (pt) | 2023-02-07 |
| WO2021229544A1 (en) | 2021-11-18 |
| KR20230012532A (ko) | 2023-01-26 |
| JP2023525155A (ja) | 2023-06-14 |
| US20230255875A1 (en) | 2023-08-17 |
| CA3177686A1 (en) | 2021-11-18 |
| AU2021272472A1 (en) | 2022-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20220179A1 (ar) | N4-هيدروكسي سيتيدين ومشتقات واستخدامات مضادة للفيروسات مرتبطة بها | |
| WO2019199861A3 (en) | Hemp extract for treatment of pain in animals | |
| BR0214772A (pt) | sistemas e métodos para o tratamento de pacientes com células lipoaspiradas processadas | |
| CN114404340B (zh) | 一种植物祛痘组合物及其应用 | |
| NZ734050A (en) | Compositions comprising povidone-iodine | |
| RU2014113663A (ru) | Композиции кожного наполнителя для лечения мелких морщин | |
| RU2013132566A (ru) | Терапевтическое средство от грыжи межпозвоночного диска | |
| BRPI0507895A (pt) | composição para o tratamento de insuficiências venosas crÈnicas, compreendendo um extrato de folhas de videira-vermelha e um agente antiinflamatório | |
| MX2024005453A (es) | Composiciones y tratamientos con nirogacestat. | |
| MX2023007080A (es) | Metodo para el tratamiento de la fibrosis. | |
| MX2023001789A (es) | Composiciones naturales para el cuidado de la piel. | |
| MX2022010960A (es) | Métodos y composiciones para tratar el trastorno por uso de cannabis y mitigar la abstinencia de cannabinoides. | |
| MX2024009868A (es) | Muteinas de interleucina-2 para el tratamiento de enfermedades autoinmunitarias. | |
| MX2022013857A (es) | Composiciones que comprenden tropoelastina reticulada con ácido hialurónico y métodos de uso de estas. | |
| WO2023164175A3 (en) | Protacs of malt1 | |
| CN106726673A (zh) | 一种保湿型具有修复抗皱功能的原液配方及其工艺 | |
| CN107137313A (zh) | 一种保湿美容液 | |
| WO2021161023A8 (en) | Compounds useful in inhibiting ketohexokinase and methods of making and using the same | |
| BR112022017257A2 (pt) | Composição e método para tratar a pele | |
| WO2022029015A3 (en) | Bacterial compositions with anti-inflammatory activity | |
| WO2021222870A3 (en) | Superoxide dismutase compositions and methods | |
| ATE458495T1 (de) | Therapeutische zubereitung für autoimmune erkrankungen | |
| WO2023178194A3 (en) | Novel microbial composition and methods of use thereof | |
| AU8988901A (en) | Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids | |
| WO2024050120A3 (en) | Nicotinamide-riboside and pterostilbene combinations to treat osteoarthritis |